Compare IRTC & FRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IRTC | FRPT |
|---|---|---|
| Founded | 2006 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Packaged Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2B | 3.6B |
| IPO Year | 2016 | 2014 |
| Metric | IRTC | FRPT |
|---|---|---|
| Price | $116.33 | $73.05 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 17 |
| Target Price | ★ $197.92 | $76.94 |
| AVG Volume (30 Days) | 683.7K | ★ 1.4M |
| Earning Date | 04-30-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 61.71 | ★ 183.87 |
| EPS | N/A | ★ 1.29 |
| Revenue | $747,138,000.00 | ★ $1,102,015,000.00 |
| Revenue This Year | $19.60 | $11.34 |
| Revenue Next Year | $15.94 | $9.13 |
| P/E Ratio | ★ N/A | $58.05 |
| Revenue Growth | ★ 26.24 | 13.01 |
| 52 Week Low | $100.85 | $46.45 |
| 52 Week High | $210.01 | $86.00 |
| Indicator | IRTC | FRPT |
|---|---|---|
| Relative Strength Index (RSI) | 44.78 | 58.23 |
| Support Level | $112.26 | $65.79 |
| Resistance Level | $121.88 | $73.07 |
| Average True Range (ATR) | 5.77 | 2.49 |
| MACD | -0.88 | -0.25 |
| Stochastic Oscillator | 10.96 | 52.33 |
iRhythm Holdings Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.
Freshpet produces and sells premium fresh pet food through its company-owned refrigerators placed in grocery, mass and club, pet specialty, and natural stores. Freshpet primarily targets dogs (likely representing well north of 90% of sales), with cats and treats nascent contributors. Geographically, the company's home US market, where all its food is produced, accounts for nearly all of sales, with exports to Canada, the United Kingdom, and other European countries being very small contributors.